About Fernando Kreutz
Form D filings for CellVax Therapeutics in 2024 list Fernando Kreutz as chief executive officer and director.
Fernando Kreutz first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Fernando Kreutz in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Fernando Kreutz works with at each company, as listed on that company's latest Form D.
CellVax Therapeutics, Inc. · Form D, Oct 4, 2024
AS
Alberto da Costa Stein
Director